For the quarter ending 2025-09-30, CTEV had -$16,643K decrease in cash & cash equivalents over the period. -$16,346K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -69,753 | -133,959 |
| Depreciation | 25,968 | 49,807 |
| Amortization of intangible assets | 85,971 | 171,942 |
| Amortization of the right-of-use asset | 679 | 1,809 |
| Loss on impairment of goodwill and intangible assets | 0 | 0 |
| Stock-based compensation | 6,991 | 13,035 |
| Deferred income taxes | 19,782 | -99,682 |
| Amortization of debt discounts and issuance costs | 3,957 | - |
| Accounts payable, accrued interest, accrued taxes, accrued expenses, and other | - | 30,096 |
| Non-cash interest expense | 12,743 | 29,036 |
| Loss (gain) on extinguishment of debt | 0 | -670 |
| Loss on sale of equity investment | -2,667 | - |
| Loss on disposal of property and equipment | -196 | -480 |
| Loss on disposal of leases | -1,696 | -5,006 |
| Gain on change in fair value of private placement warrants and unvested founder shares | 0 | 0 |
| Trade accounts receivable, net | 3,413 | 33,821 |
| Prepaid taxes | 33,019 | -6,747 |
| Prepaid expenses, other current and non-current assets | -6,925 | 7,631 |
| Accounts payable | -47,401 | - |
| Other accrued expenses, accrued interest and accrued liabilities | 37,196 | - |
| Operating leases, net | -1,232 | -2,354 |
| Net cash provided by operating activities | 19,857 | 31,181 |
| Purchases of property and equipment | 36,203 | 63,489 |
| Proceeds from sale of equity investment | 13,333 | - |
| Net cash used in investing activities | -22,870 | -63,489 |
| Repayments of term loan | 3,671 | 3,674 |
| Repurchase of senior convertible pik notes-Senior PIKNotes | 0 | 0 |
| Taxes paid on settlement of vested share awards | 607 | 2,884 |
| Borrowings on 2025 revolving credit facility | 95,000 | 130,000 |
| Repayment of 2025 revolving credit facility | 105,000 | 50,000 |
| Purchase of treasury stock | 0 | 0 |
| Payment of debt issuance costs | 0 | 4,267 |
| Proceeds from issuance of common stock under employee stock purchase plan | 648 | 749 |
| Net cash provided by (used in) financing activities | -13,630 | 69,924 |
| Net increase in cash, cash equivalents and restricted cash | -16,643 | 37,616 |
| Cash and cash equivalents at beginning of period | 29,672 | - |
| Cash and cash equivalents at end of period | 50,645 | - |
Claritev Corp (CTEV)
Claritev Corp (CTEV)